Company Description
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.
It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate.
The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems.
In addition, it offers post-contract customer support, installation, training, and other professional services.
The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally.
Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
| Country | United States |
| Founded | 1990 |
| IPO Date | Feb 8, 2007 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 987 |
| CEO | Suzanne Winter |
Contact Details
Address: 1240 Deming Way Madison, Wisconsin 53717-1954 United States | |
| Phone | 608 824 2800 |
| Website | accuray.com |
Stock Details
| Ticker Symbol | ARAY |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0001138723 |
| CUSIP Number | 004397105 |
| ISIN Number | US0043971052 |
| Employer ID | 20-8370041 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Suzanne Winter M.B.A. | President, Chief Executive Officer and Director |
| Ali Pervaiz | Senior Vice President and Chief Financial Officer, Interim Principal Accounting officer |
| Michael Hoge | Senior Vice President of Global Operations |
| Sandeep Chalke | Senior Vice President and Chief Commercial Officer |
| John M. Dunn | Senior Vice President, Chief Information and Security Officer |
| Beth Kaplan | Public Relations Director |
| Melanie Rivers | Senior Vice President, Chief Human Resources Officer |
| Jim Dennison | Senior Vice President, Chief Quality and Development Officer |
| Dr. Seth Blacksburg M.B.A., M.D. | Senior Vice President and Chief Medical Officer |
| Roger Cao | President and GM of APAC REGION |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 6, 2024 | 10-Q | Quarterly Report |
| Nov 6, 2024 | 8-K | Current Report |
| Oct 21, 2024 | 8-K | Current Report |
| Oct 15, 2024 | 8-K | Current Report |
| Oct 4, 2024 | ARS | Filing |
| Oct 4, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Oct 4, 2024 | DEF 14A | Other definitive proxy statements |
| Oct 2, 2024 | SCHEDULE 13G | Filing |
| Sep 19, 2024 | 10-K | Annual Report |
| Sep 16, 2024 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |